Francois Delvoye and Jean‐Philippe Désilles: Neutrophil Activation Affects Acute Ischemic Stroke Clinical Outcomes?
Francois Delvoye, Lecturer at the University of Liège (Belgium) and Research Coordinator at the Biological Resource Center of the Rothschild Foundation Hospital (Paris), shared an insightful post on LinkedIn:
”Check out our lab’s latest publication in JAHA!
Neutrophil activation at 24 hours after mechanical thrombectomy for acute ischemic stroke is correlated with 3-month clinical outcome.
Another argument for targeting neutrophil activation — as investigated in the NETs-Target clinical trial (NCT04785066), led by Prof. Jean-Philippe DESILLES at the Fondation Adolphe de Rothschild!”
Read the full article here.
Article: Neutrophil Activation 24 Hours After an Endovascular Therapy–Treated Acute Ischemic Stroke Is Associated With 3‐Month Clinical Outcome
Authors: François Delvoye, Benjamin Maier, Mialitiana Solonomenjanahary, Julien Labreuche, Lucas Di Meglio, Véronique Ollivier, Pierre Seners, Michel Piotin, Raphaël Blanc, Simon Escalard, Mikael Mazighi, Benoit Ho‐Tin‐Noé, Jean‐Philippe Désilles
Stay updated on the latest scientific advancements in the field of stroke with Hemostasis Today.
-
Aug 5, 2025, 17:44Brain Haemorrhage: A Critical Awareness Guide by Dr. Dilip S. Kiyawat
-
Aug 5, 2025, 07:09EHJ Issue 46-29 Explores Cardio-Oncology and Ischaemic Syndrome Management – Now Online
-
Aug 5, 2025, 04:46When the Same Risk Can Be a Benefit – The Balance Between Bleeding and Thrombosis
-
Aug 5, 2025, 04:02Julia Rauscher and Cathy Verbraeken Lead EHC Workshop on Best Practices
-
Aug 5, 2025, 02:28Personalized Perioperative Management in Hemophilia: Key Insights from Heghine Khachatryan
-
Aug 5, 2025, 19:27Ming Y Lim Presents the Clot Cases Conference: Model of Advanced Multidisciplinary Thrombosis Care
-
Aug 5, 2025, 18:49Francois Delvoye and Jean‐Philippe Désilles: Neutrophil Activation Affects Acute Ischemic Stroke Clinical Outcomes?
-
Aug 4, 2025, 17:29MADD: First Causal Gene for Quantitative Von Willebrand Disease Discovered
-
Aug 4, 2025, 16:13Nicolas Gendron on TITAN’s Recent Study: Insights on Managing Pregnancy in Antithrombin Deficiency
-
Aug 4, 2025, 01:59Michael Makris Posts Haemophilia Journal Article Reassessing UK Blood Inquiry
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center
-
Aug 3, 2025, 12:03Elias Bouchi Presents Werfen EEMEA Talks on Hemostasis: Clot Stories Season 3